Dr. Halpern is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18 E 41st St
Fl 14
New York, NY 10017Phone+1 917-503-9148Fax+1 833-449-4351
Summary
- Dr. Joshua Halpern MD MS is a board-certified and fellowship-trained Reproductive Urologist practicing in New York and throughout the Northeast. He serves as both the Regional Medical Director in the Northeast and Chief Scientific Officer for Posterity Health. He is also on faculty at Northwestern University Feinberg School of Medicine.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2013 - 2018
Weill Cornell Graduate School of Medical SciencesMS, Health Policy and Economics, 2015 - 2016- New York Presbyterian Hospital (Cornell Campus)Internship, Surgery, 2012 - 2013
Weill Cornell MedicineClass of 2012, MD, Alpha Omega Alpha
Certifications & Licensure
CO State Medical License 2024 - 2027
DE State Medical License 2023 - 2027
IL State Medical License 2018 - 2026
MA State Medical License 2023 - 2026
ME State Medical License 2023 - 2026
PA State Medical License 2024 - 2026
RI State Medical License 2024 - 2026
American Board of Urology Urology- Join now to see all
Publications & Presentations
PubMed
- Male Factor Infertility and the Rural-Urban Continuum.Devon M Langston, Kiarad Fendereski, Joshua Halpern, Ijeoma N Iko, Kenneth Aston
Urology. 2025-03-01 - The association of hypertension and antihypertensive medications on semen parameters among men presenting for fertility evaluation.Daniel R Greenberg, Luis C Gago, Sai Kaushik S R Kumar, Evan J Panken, Kian Asanad
Andrology. 2025-02-06 - 1 citationsPrevalence of infertility and barriers to family building among male physicians.Jasmine S Lin, Justin M Dubin, Jonathan Aguiar, Robert E Brannigan, Joshua A Halpern
Andrology. 2025-02-01
Press Mentions
Are GLP-1s the Newest Fertility Treatment?November 8th, 2024- Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone TherapyDecember 5th, 2022
- Health News | Online Platforms Give Access to Testosterone Therapy Without Caution: StudyDecember 5th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
